Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Short term Debt (2019 - 2022)

Historic Short term Debt for Pharming (PHAR) over the last 4 years, with Q3 2022 value amounting to $143000.0.

  • Pharming's Short term Debt fell 6295.34% to $143000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $143000.0, marking a year-over-year decrease of 6295.34%. This contributed to the annual value of $165000.0 for FY2021, which is 9934.0% down from last year.
  • According to the latest figures from Q3 2022, Pharming's Short term Debt is $143000.0, which was down 6295.34% from $152000.0 recorded in Q2 2022.
  • Pharming's 5-year Short term Debt high stood at $19.7 million for Q4 2019, and its period low was $143000.0 during Q3 2022.
  • In the last 4 years, Pharming's Short term Debt had a median value of $189000.0 in 2021 and averaged $2.4 million.
  • Its Short term Debt has fluctuated over the past 5 years, first crashed by 9895.52% in 2020, then plummeted by 1428.57% in 2022.
  • Pharming's Short term Debt (Quarter) stood at $19.7 million in 2019, then plummeted by 98.96% to $206266.1 in 2020, then fell by 19.58% to $165875.8 in 2021, then fell by 13.79% to $143000.0 in 2022.
  • Its last three reported values are $143000.0 in Q3 2022, $152000.0 for Q2 2022, and $162000.0 during Q1 2022.